Skip to main content
. 2017 Jul 31;97(4):1062–1069. doi: 10.4269/ajtmh.17-0221

Table 3.

Demographic, clinical and laboratory profile of dengue and nondengue patients, Nepal

Variable Dengue (N = 128) Nondengue (N = 154) Total (N = 282) P value
Demographic
 Age in years, median (IQR) 29.5 (21.3–40.0) 26.0 (17.0–40.0) 28.0 (19.0–40.0) 0.004
 Residence, urban 93 (72.7) 65 (42.2) 158 (56.0) < 0.001
 Prior visit to clinics/pharmacy 58 (45.3) 67 (43.5) 125 (44.3) 0.761
Clinical
 DOI, median (IQR) 4.5 (3.0–7.0) 4.0 (2.0–7.0) 4.0 (2.8–7.0) 0.503
 Fever 128 (100.0) 154 (100.0) 282 (100.0)
 Headache 118 (92.2) 134 (87.0) 252 (89.4) 0.161
 Nausea 91 (71.1) 97 (63.0) 188 (66.7) 0.150
 Vomiting 46 (35.9) 37 (24.0) 83 (29.4) 0.029
 Rash 48 (37.5) 21 (13.6) 69 (24.5) < 0.001
 Myalgia 44 (34.4) 52 (33.8) 96 (34.0) 0.914
 Bleeding 18 (14.1) 4 (2.6) 22 (7.8) < 0.001
 Retro-orbital pain 56 (43.8) 39 (25.3) 95 (33.7) 0.001
 Diarrhea 29 (22.7) 25 (16.2) 54 (19.1) 0.172
 Sore throat 9 (7.0) 22 (14.3) 31 (11.0) 0.053
 Chills 12 (9.4) 37 (24.0) 49 (17.4) 0.001
 Abdominal pain 36 (28.1) 49 (31.8) 85 (30.1) 0.501
 Arthralgia 19 (14.8) 17 (11.0) 36 (12.8) 0.340
 Hepatomegaly 43 (33.6) 35 (22.7) 78 (27.7) 0.042
 Splenomegaly 17 (13.3) 11 (7.1) 28 (9.9) 0.086
Laboratory
 Elevated AST (> 50 IU/L) 81 (63.3) 44 (28.6) 125 (44.3) < 0.001
 Elevated ALT (> 50 IU/L) 57 (44.5) 28 (18.2) 85 (30.1) < 0.001
 Thrombocytopenia 75 (58.6) 35 (22.7) 110 (39.0) < 0.001
 Leucopenia 55 (43.0) 40 (26.0) 95 (33.7) 0.003

AST = serum aspartate aminotransferase; ALT = serum alanine aminotransferase; DOI = days postonset of illness; IQR = interquartile range; IU/L = international unit/liter. Figures in the parenthesis indicate percentages unless otherwise indicated. P value was calculated using Mann–Whitney U test for age and DOI, and χ2 test for all categorical variables.